Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW572016 plus paclitaxel vs placebo plus paclitaxel in previously untreated advanced or metastatic breast cancer
2004-001999-40Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in breast cancer comparing Lapatinib + paclitaxel with Placebo + paclitaxel (2 arms). Primary endpoint: Time to progression. Started Oct 2004; status: completed.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2004-001999-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001999-40.